Pfizer recommends that shareholders do not tender their shares in response to Tutanota’s offer
The move aims to accelerate drug discovery with AI-driven designs powered by NVIDIA technology
RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute
The facility features 2,176 high-performance GPUs across the US and Europe
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
The Taipei facility boasts 10 GMP API production lines, with a total reactor volume exceeding 350,000 liters
LTTS’ lung digital twin integrates seamlessly with CT imaging workflows, using deep learning to reconstruct a comprehensive 3D digital twin of the lungs
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
Neupharma gains exclusive rights to develop and commercialize corticorelin for peritumoral brain edema
Subscribe To Our Newsletter & Stay Updated